Advance Search
DIGN Xiaolong, JING Shunping. Effect of entecavir combined with pegylated interferon in patients with chronic hepatitis B[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 18-22, 26. DOI: 10.7619/jcmp.201913005
Citation: DIGN Xiaolong, JING Shunping. Effect of entecavir combined with pegylated interferon in patients with chronic hepatitis B[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 18-22, 26. DOI: 10.7619/jcmp.201913005
shu

Effect of entecavir combined with pegylated interferon in patients with chronic hepatitis B

  • Department of Digestion, Xianyang First People′s Hospital, Xianyang, Shaanxi, 712000

More Information
  • Received Date: May 10, 2019
  • Accepted Date: June 09, 2019
  • Available Online: February 23, 2021
  • Published Date: July 14, 2019
    Graphical Abstract
    • Abstract
  •   Objective  To investigate the effect of entecavir combined with pegylated interferon on normalization rate of glutamic-pyruvic transaminase(ALT), clearance rate of hepatitis B E antigen (HBeAg) and conversion rate of hepatitis B E antibody (HBeAb) in patients with chronic hepatitis B(CHB).
      Methods  A total of 120 patients with CHB were divided into two groups, both groups were treated with basic therapy. The control group was treated with pegylated interferon, and the observation group with entecavir combined with pegylated interferon. The ALT normalization rate, clearance rate of HBeAg, conversion rate of HBeAb and viral breakthrough rate of the two groups were observed and compared. At the same time, the adverse reactions during the treatment were observed.
      Results  After treatment, the total effective rate of the observation group was significantly higher than that of the control group(P < 0.05); the serum ALT levels of the two groups after 6, 12 and 24 weeks of treatment were significantly improved compared with treatment before(P < 0.05), but the between-group differences were not observed (P>0.05); after 12 and 24 weeks of treatment, the normalization rate of of ALT, clearance rate of HBeAg and conversion rate of HBeAb in the observation group were significantly higher than those in the control group (P < 0.05); after 12 and 24 week of treatment, the viral breakthrough rate in the observation group was significantly lower than that in the control group(P < 0.05); after 24 week of treatment, the levels of Th1/Th2 cytokines in both groups were significantly improved compared with before treatment(P < 0.05); after 24 week of treatment, INF-γ and IL-6 levels in the observation group were significantly better than those in the control group(P < 0.05).
      Conclusion  Entecavir combined with pegylated interferon in the treatment of CHB patients has better clinical efficacy, which can effectively inhibit HBV replication, and has higher safety and synergistic antiviral effect.
    • FullText(HTML)
    • References (20)
  • [1]
    中华医学会感染病学分会. 肝脏炎症及其防治专家共识[J]. 中国实用内科杂志, 2014, 22(2): 94-103. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201402016.htm
    [2]
    Kim V, Abreu R M, Nakagawa D M, et al. Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis[J]. J Viral Hepat, 2016, 23(3): 154-169. doi: 10.1111/jvh.12418
    [3]
    中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版)[J]. 中华流行病学杂志, 2011, 32(4): 405-415. doi: 10.3760/cma.j.issn.0254-6450.2011.04.019
    [4]
    焦向鲲, 高玉金, 王春颖, 等. 恩替卡韦联合长效干扰素治疗HBeAg阳性慢性乙型肝炎的临床观察[J]. 中国药房, 2017, 28(32): 4552-4555. doi: 10.6039/j.issn.1001-0408.2017.32.24
    [5]
    谢娜, 张大志. 第十三次全国病毒性肝炎及肝病学术会议纪要[J]. 中华肝脏病杂志, 2007, 15(8): 631-632. doi: 10.3760/j.issn:1007-3418.2007.08.026
    [6]
    朱丽, 王丽, 曾义岚, 等. 聚乙二醇干扰素α-2a联合恩替卡韦治疗高病毒载量HBeAg阳性慢性乙型肝炎的临床研究[J]. 实用药物与临床, 2016, 19(1): 110-113. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201601029.htm
    [7]
    Keshvari M, Alavian S M, Aghaee B, et al. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization[J]. Transfus Med, 2014, 24(6): 411-417. doi: 10.1111/tme.12163
    [8]
    程月红, 杜义敏, 刘云燕, 等. 慢性肝炎病毒感染患者心理状况研究进展[J]. 河北医药, 2015, 37(20): 3165-3167. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201520045.htm
    [9]
    Ito H, Ando T, Nakamura M, et al. Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand[J]. J Viral Hepat, 2017, 24(2): 155-162. doi: 10.1111/jvh.12629
    [10]
    赵玉倩, 许杏梅, 杨慧娟, 等. 六味五灵片治疗慢性乙肝ALT复常率、HBeAg转阴率及HBeAb转换率的meta分析[J]. 中国中西医结合消化杂志, 2016, 24(5): 362-366. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201605014.htm
    [11]
    刘楷, 沈妍希, 凌宁, 等. 聚乙二醇干扰素α-2a治疗慢性乙型肝炎过程中外周血γδT细胞的变化及其临床意义[J]. 中华肝脏病杂志, 2018, 26(5): 365-370. doi: 10.3760/cma.j.issn.1007-3418.2018.05.010
    [12]
    Takkenberg B, Terpstra V, Zaaijer H, et al. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir[J]. J Gastroenterol Hepatol, 2011, 26(10): 1527-1535. doi: 10.1111/j.1440-1746.2011.06766.x
    [13]
    Hansen B E, Buster E H, Steyerberg E W, et al. Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment[J]. J Med Virol, 2010, 82(7): 1135-1142. doi: 10.1002/jmv.21778
    [14]
    Chan P, Mould D R, Tarif M A, et al. Using population pharmacokinetic and pharmacodynamic analyses of entecavir in pediatric subjects to simplify dosing recommendations[J]. Clin Pharmacokinet, 2016, 55(12): 1559-1572. doi: 10.1007/s40262-016-0420-5
    [15]
    王洪旗, 肖璐, 孙曦, 等. 恩替卡韦联合聚乙二醇干扰素α-2a治疗慢性乙型肝炎的临床疗效[J]. 现代生物医学进展, 2017, 17(30): 5887-5891. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201730020.htm
    [16]
    European Association For The Study Of The Liver. EASL clinical practice guidelines. Management of chronic hepatitis B[J]. Gastroenterol Clin Biol, 2009, 33(6/7): 539-554. http://onlinelibrary.wiley.com/resolve/reference/PMED?id=21371579
    [17]
    曾文, 袁静, 刘映霞, 等. 聚乙二醇干扰素alpha-2a联合恩替卡韦治疗高病毒载量HBeAg阳性慢性乙型肝炎的临床研究[J]. 中华实验和临床病毒学杂志, 2013, 27(2): 115-118. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201601029.htm
    [18]
    林文, 孙洪青. 聚乙二醇干扰素α-2a、恩替卡韦单用与联合应用治疗慢性乙型肝炎的疗效分析[J]. 临床内科杂志, 2017, 34(1): 52-54. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201730020.htm
    [19]
    祝娟娟, 吴娴, 朱霞, 等. 聚乙二醇干扰素联合恩替卡韦治疗15例慢乙肝的疗效观察[J]. 贵州医药, 2016, 40(1): 76-77. https://www.cnki.com.cn/Article/CJFDTOTAL-GZYI201601033.htm
    [20]
    梁冰, 殷海燕. 聚乙二醇干扰素联合恩替卡韦治疗慢性乙肝的临床分析[J]. 中国继续医学教育, 2018, 10(29): 133-135. https://www.cnki.com.cn/Article/CJFDTOTAL-JXUY201829062.htm
    • Related Articles

  • Related Articles

    [1]ZHANG Si, LI Hui. Monocentric analysis of risk factors for pulmonary tuberculosis co-infected with pulmonary aspergillosis[J]. Journal of Clinical Medicine in Practice, 2025, 29(6): 45-50. DOI: 10.7619/jcmp.20244101
    [2]JU Jiyin. Analysis of risk factors of postoperative pulmonary infection in patients with esophageal cancer and its intensive nursing[J]. Journal of Clinical Medicine in Practice, 2018, (6): 60-63. DOI: 10.7619/jcmp.201806018
    [3]WANG Ling, LI Jingjiang, ZHOU Yu. Effect of nursing intervention in prevention of pulmonary infection in emergency intensive care unit[J]. Journal of Clinical Medicine in Practice, 2018, (2): 32-34. DOI: 10.7619/jcmp.201802010
    [4]ZHANG Yue, YU Xiaojiang. Effect of comfort care on improving pulmonary infection of chronic obstructive pulmonary disease patients combined with pulmonary heart disease in ICU[J]. Journal of Clinical Medicine in Practice, 2017, (8): 30-33,38. DOI: 10.7619/jcmp.201708010
    [5]WANG Xuena. Clinical nursing of patients with bronchial obstruction caused by Y stent implantation[J]. Journal of Clinical Medicine in Practice, 2017, (6): 104-106. DOI: 10.7619/jcmp.201706032
    [6]CHEN Lu, MENG Yanni, HUANG Jianbao, CHEN Yanping. Application of fiber bronchoscope in diagnosis and treatment of children mycoplasma pneumoniae pneumonia complicated with pulmonary atelectasis[J]. Journal of Clinical Medicine in Practice, 2015, (23): 78-81. DOI: 10.7619/jcmp.201523024
    [7]ZHANG Xiayi, WANG Huize. Effects of nursing care intervention in operating room on preventing postoperative pulmonary infection[J]. Journal of Clinical Medicine in Practice, 2014, (20): 94-95,101. DOI: 10.7619/jcmp.201420029
    [8]LI Ying. Comprehensive nursing intervention of lung infection in patients with severe craniocerebral injury combined with pulmonary contusion[J]. Journal of Clinical Medicine in Practice, 2014, (6): 35-38. DOI: 10.7619/jcmp.201406012
    [9]ZHAO Zhihong, QIU Hao. Related factors of postoperative pulmonary complications in elderly patients with esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2013, (16): 101-103. DOI: 10.7619/jcmp.201316039
    [10]WANG Bei-hong, WANG Zhen-kai, CHENG Bao-jing, WAN Yu, ZHANG Ke. The application of bronchoscopy in the treatment of postoperative atelectasis in children with thoracic surgery[J]. Journal of Clinical Medicine in Practice, 2011, (17): 92-93. DOI: 10.3969/j.issn.1672-2353.2011.17.032

  • Cited by

    Periodical cited type(8)

    1. 田美莉. 氨甲环酸联合葡萄糖酸钙治疗产后出血的临床效果. 妇儿健康导刊. 2024(04): 90-92 .
    2. 李相茹. 氨甲环酸联合麦角新碱预防剖宫产产后出血的效果. 中国民康医学. 2024(07): 71-74 .
    3. 郭丽平，陈秋连，陈琳. 氨甲环酸联合缩宫素预防瘢痕子宫再次分娩后恶露不尽的效果及对凝血功能的影响. 中国医学创新. 2024(17): 145-148 .
    4. 刘伟，曹玉枝，田润芝，曹晨，李桂青. 悬浮红细胞与新鲜冰冻血浆不同比例输注联合氨甲环酸治疗产后出血的效果对比. 中国妇幼保健. 2024(16): 3034-3037 .
    5. 王晨. 氨甲环酸联合麦角新碱对产后出血产妇的治疗效果. 实用中西医结合临床. 2024(12): 35-37+128 .
    6. 张美琳，于楠楠. 麦角新碱联合氨甲环酸治疗产后宫缩乏力性出血的临床效果以及对子宫复旧、凝血功能的影响. 中国当代医药. 2024(33): 88-91 .
    7. 符海萍. 氨甲环酸联合缩宫素对预防剖宫产产后出血的效果及改善凝血功能的临床研究. 现代医学与健康研究电子杂志. 2023(17): 56-58 .
    8. 彭玲玲，郝然，吴俞萱，李娟，谌艳. 局部应用氨甲环酸联合磺胺嘧啶银脂质水胶敷料对骨科大手术后切口渗血的影响. 中国当代医药. 2023(36): 46-50 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (307) PDF downloads (6) Cited by(9)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return